Determination of antigen components in inactivated SARS-CoV-2 vaccine using ultra-high-performance liquid chromatography tandem mass spectrometry

Key Points

• The analysis reveals key antigen components of the inactivated SARS-CoV-2 vaccine, enhancing understanding of immune responses.
• Using ultra-high-performance liquid chromatography tandem mass spectrometry, specific components were accurately identified.
• The research highlights the importance of identifying antigen profiles for effective vaccine development and optimization.
• These findings may lead to improved vaccine formulations and effectiveness in combating COVID-19.